It has been reported that IP-10 has an antiproliferative effect in vitro [42] and that it plays an important role in Th1 cell-derived inflammatory and autoimmune diseases, such as Hashimoto’s disease, Graves’ disease, and type 1 diabetes mellitus [43, 44]. This evidence concerns the gene CXCL10 and Graves disease.